Annual Statements Open main menu

Inrad Optics, Inc. - Quarter Report: 2011 September (Form 10-Q)

Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
 (Mark One)
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended  SEPTEMBER 30, 2011
 
OR
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from __________ to __________
 
Commission file number  0-11668
 
PHOTONIC PRODUCTS GROUP, INC.
(Exact name of registrant as specified in its charter)
 
New Jersey
22-2003247
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification Number)
 
181 Legrand Avenue, Northvale, NJ  07647
(Address of principal executive offices)
(Zip Code)
 
(201) 767-1910
(Registrant’s telephone number, including area code)

_____________________________________________________________________
(Former name, former address and formal fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o       
 
      Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See definition of “large accelerated filer, accelerated filer and smaller reporting company” in Rule 12b-2 of the exchange Act.  (Check one):

Large accelerated filer  o
 
Accelerated filer  o
 
Non-accelerated filer  o
 
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x
 
Common shares of stock outstanding as of November 14, 2011:
 
11,708,964 shares

 
 

 

PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIES
 
INDEX
 
Part I.
CONDENSED FINANCIAL INFORMATION
       
           
Item 1.
Consolidated Financial Statements:
       
           
 
Condensed consolidated balance sheets as of September 30, 2011 (unaudited) and December 31, 2010 (audited)
    2  
           
 
Condensed consolidated statements of operations for the three and nine months ended September 30, 2011 and 2010 (unaudited)
    3  
           
 
Condensed consolidated statements of cash flows for the nine months ended September 30, 2011 and 2010 (unaudited)
    4  
           
 
Notes to condensed consolidated financial statements (unaudited)
    5  
           
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
    10  
           
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
    14  
           
Item 4.
Controls and Procedures
    14  
           
Part II.
OTHER INFORMATION
       
           
Item 1.
Legal Proceedings
    15  
           
Item 1A.
Risk Factors
    15  
           
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
    15  
           
Item 3.
Defaults upon Senior Securities
    15  
           
Item 4.
[Reserved]
    15  
           
Item 5.
Other Information
    15  
           
Item 6.
Exhibits
    15  
           
Signatures
      16  
 
 
1

 
 
PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

   
September 30,
   
December 31,
 
   
2011
   
2010
 
   
(Unaudited)
   
(Audited)
 
Assets
           
Current assets:
           
Cash and cash equivalents
  $ 3,787,329     $ 4,365,045  
Accounts receivable (net of allowance for doubtful accounts of $15,000 in 2011 and 2010)
    2,020,658       2,224,592  
Inventories, net
    2,881,196       2,390,876  
Other current assets
    195,274       119,243  
Total current assets
    8,884,457       9,099,756  
Plant and equipment:
               
Plant and equipment,  at cost
    15,105,883       14,879,508  
Less: Accumulated depreciation and amortization
    (13,465,700 )     (12,876,163 )
    Total plant and equipment
    1,640,183       2,003,345  
Precious Metals
    474,935       157,443  
Deferred Income Taxes
    408,000       408,000  
Goodwill
    311,572       311,572  
Intangible Assets, net
    535,529       594,452  
Other Assets
    44,499       47,235  
Total Assets
  $ 12,299,175     $ 12,621,803  
                 
Liabilities and Shareholders’ Equity
               
Current Liabilities:
               
Current portion of other long term notes
  $ 9,000     $ 9,000  
Accounts payable and accrued liabilities
    1,071,475       836,190  
Customer advances
    500,791       441,987  
Total current liabilities
    1,581,266       1,287,177  
                 
Related Party Convertible Notes Payable
    2,500,000       2,500,000  
Accrued Interest on Related Party Convertible Notes Payable
    225,000       1,125,000  
Other Long Term Notes, net of current portion
    328,875       335,874  
Total liabilities
    4,635,141       5,248,051  
                 
Commitments
               
                 
Shareholders’ Equity:
               
Common stock: $.01 par value; 60,000,000 authorized shares; 11,713,564 shares issued at September 30, 2011 and 11,562,656
     issued at December 31, 2010
    117,137       115,626  
Capital in excess of par value
    17,668,589       17,402,528  
Accumulated deficit
    (10,106,742 )     (10,129,452 )
      7,678,984       7,388,702  
Less - Common stock in treasury, at cost (4,600 shares)
    (14,950 )     (14,950 )
Total shareholders’ equity
    7,664,034       7,373,752  
Total Liabilities and Shareholders’ Equity
  $ 12,299,175     $ 12,621,803  
 
See Notes to Condensed Consolidated Financial Statements (Unaudited)
 
 
2

 
 
PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
   
Three Months Ended
 September 30,
   
Nine Months Ended
 September 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
Total revenue
  $ 3,328,761     $ 2,478,581     $ 9,791,429     $ 7,451,118  
                                 
Cost and expenses:
                               
Cost of goods sold
    2,420,856       1,983,903       7,226,927       6,160,234  
Selling, general and administrative expenses
    792,132       741,657       2,449,161       2,390,403  
      3,212,988       2,725,560       9,676,088       8,550,637  
                                 
Income (loss) from operations
    115,773       (246,979 )     115,341       (1,099,519 )
                                 
Other income (expense):
                               
Interest expense—net
    (32,042 )     (34,776 )     (96,257 )     (104,660 )
Gain (loss) on sale of plant and equipment
                3,626       (944 )
      (32,042 )     (34,776 )     (92,631 )     (105,604 )
                                 
Net income (loss) before income taxes
    83,731       (281,755 )     22,710       (1,205,123 )
                                 
Income tax (provision) benefit
                       
                                 
Net income (loss)
  $ 83,731     $ (281,755 )   $ 22,710     $ (1,205,123 )
                                 
Net income (loss) per common share — basic
  $ 0.01     $ (0.02 )   $ 0.00     $ (0.10 )
                                 
Net income (loss) per common share — diluted
  $ 0.01     $ (0.02 )     0.00     $ (0.10 )
                                 
Weighted average shares outstanding— basic
    11,708,964       11,558,056       11,645,389       11,512,335  
                                 
Weighted average shares outstanding— diluted
    11,799,161       11,558,056       11,743,104       11,512,335  

See Notes to Condensed Consolidated Financial Statements (Unaudited)

 
3

 
 
PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

   
Nine Months Ended
September 30,
 
   
2011
   
2010
 
             
Cash flows from operating activities:
           
Net income (loss)
  $ 22,710     $ (1,205,123 )
                 
Adjustments to reconcile net income (loss) to cash provided by operating activities:
               
Depreciation and amortization
    650,507       707,462  
401K common stock contribution
    129,998       154,535  
(Gain) loss on sale of fixed assets
    (3,626 )     944  
Stock based compensation
    119,314       121,464  
Changes in operating assets and liabilities:
               
        Accounts receivable
    203,934       443,060  
        Inventories, net
    (490,320 )     (336,397 )
        Other current assets
    (76,031 )     53,817  
        Other assets
    2,736       (5,886 )
        Accounts payable and accrued liabilities
    235,285       595,777  
        Customer advances
    58,804       (232,011 )
        Accrued Interest on Related Party Convertible Notes Payable
    (900,000 )      
Total adjustments and changes
    (69,399 )     1,502,765  
Net cash (used by) provided by operating activities
    (46,689 )     297,642  
                 
Cash flows from investing activities:
               
Capital expenditures
    (230,796 )     (124,032 )
Purchase of precious metals
    (317,492 )      
Proceeds from sale of plant and equipment
    6,000        
Net cash (used in) investing activities
    (542,288 )     (124,032 )
                 
Cash flows from financing activities:
               
Redemption of restricted stock units
    (740 )     (1,239 )
Proceeds from exercise of stock options
    19,000       8,500  
Principal payments of notes payable-other
    (6,999 )     (6,761 )
Net cash provided by financing activities
    11,261       500  
                 
Net (decrease) increase in cash and cash equivalents
    (577,716 )     174,110  
                 
Cash and cash equivalents at beginning of period
    4,365,045       4,069,310  
                 
Cash and cash equivalents at end of period
  $ 3,787,329     $ 4,243,420  
                 
Supplemental Disclosure of Cash Flow Information:
               
         Interest paid
  $ 1,023,000     $ 11,000  
         Income taxes paid (refund)
  $     $ (74,000 )
 
See Notes to Condensed Consolidated Financial Statements (Unaudited)
 
 
4

 
 
PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
 
NOTE 1 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements include the accounts of Photonic Products Group, Inc. and its subsidiaries (collectively, the “Company”).  All significant intercompany balances and transactions have been eliminated.
 
 The condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year.  For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.
 
In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued.

Management Estimates
 
These unaudited condensed financial statements and related disclosures have been prepared in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements.  Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate.  As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions.  Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.
 
Inventories
 
Inventories are stated at the lower of cost (first-in-first-out basis) or market.  The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow-moving or discontinued.  Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.
 
Inventories are comprised of the following and are shown net of inventory reserves:

   
September 30,
2011
   
December 31, 2010
 
   
(in thousands)
 
Raw materials
  $ 1,041     $ 1,103  
Work in process, including manufactured parts and components
    1,130       806  
Finished goods
    710       482  
    $ 2,881     $ 2,391  
 
 
5

 
 
Income Taxes
 
The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns.  Deferred tax assets and liabilities are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.
 
For the three and nine months ended September 30, 2011 and 2010, the Company did not record a current provision for either state or federal income taxes due to the availability of net operating loss carryforwards to offset against federal and state income taxes.
 
As of September 30, 2011, the Company has recognized a net deferred tax asset balance in the amount of $408,000, which is the portion of the total net deferred tax balance of $2,521,000 that the Company’s management is reasonably assured will be fully utilized in future periods.  In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income consistent with the plans and estimates that management uses to manage the underlying business.  The Company’s valuation allowance of $2,113,000 as of September 30, 2011 will be maintained until management concludes that it is more likely than not that the remaining deferred tax assets will be realized. When sufficient positive evidence exists, the Company’s income tax expense will be reduced by the decrease in its valuation allowance.  An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.
 
Net Income (Loss) per Common Share
 
Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares and common stock equivalents outstanding, calculated on the treasury stock method for options, stock grants and warrants using the average market prices during the period, including potential common shares issuable upon conversion of outstanding convertible notes, except if the effect on the per share amounts is anti-dilutive.
 
For the three and nine months ended September 30, 2011, 2,500,00 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes and 225,000 common shares and 168,750 warrants issuable on conversion of accrued interest on related party convertible notes were excluded from the computation of diluted net income per common share because their effect is anti-dilutive.
 
For the three and nine months ended September 30, 2010, 811,000 common stock options and grants, 2,500,000 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes and 1,087,500 common shares and 815,625 warrants issuable on conversion of accrued interest on related party convertible notes were excluded from the computation of diluted net loss per common share because their effect is anti-dilutive.
 
 
6

 
 
A reconciliation of the shares used in the calculation of basic and diluted earnings per common share is as follows:

   
Three Months Ended
September 30, 2011
   
Three Months Ended
September 30, 2010
 
   
Income (Loss)
   
Shares
   
Per Share
   
Income (Loss)
   
Shares
   
Per Share
 
   
(Numerator)
   
(Denominator)
   
Amount
   
(Numerator)
   
(Denominator)
   
Amount
 
                                     
Basic Income (Loss) Per Share:
                                   
Net Income (Loss)
  $ 83,731       11,708,964     $ 0.01     $ (281,755 )     11,558,056     $ (0.02 )
Effect of dilutive securities:
                                               
Options and stock grants
          90,197                              
                                                 
Diluted Income (Loss) Per Share:
                                               
Net Income (Loss) Applicable to Common Shareholders
  $ 83,731       11,799,161     $ 0.01     $ (281,755 )     11,558,056     $ (0.02 )
 
   
Nine Months Ended
September 30, 2011
   
Nine Months Ended
September 30, 2010
 
   
Income (Loss)
   
Shares
   
Per Share
   
Income (Loss)
   
Shares
   
Per Share
 
   
(Numerator)
   
(Denominator)
   
Amount
   
(Numerator)
   
(Denominator)
   
Amount
 
                                     
Basic Income (Loss) Per Share:
                                   
Net Income (Loss)
  $ 22,710       11,645,389     $ 0.00     $ (1,205,123 )     11,512,335     $ (0.10 )
Effect of dilutive securities:
                                               
Options and stock grants
          97,715                              
                                                 
Diluted Income (Loss) Per Share:
                                               
Net Income (Loss) Applicable to Common Shareholders
  $ 22,710       11,743,104     $ 0.00     $ (1,205,123 )     11,512,335     $ (0.10 )
 
Stock-Based Compensation
 
Stock-based compensation expense is estimated at the grant date based on the fair value of the award.  The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value of restricted stock units granted is based on the closing market price of the Company’s common stock on the date of the grant.  The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.
 
Recently Adopted Accounting Standards
 
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, “Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (“IFRS”).” This pronouncement was issued to provide a consistent definition of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and IFRS. ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for Level 3 fair value measurements. This pronouncement is effective for reporting periods beginning on or after December 15, 2011, with early adoption prohibited. The new guidance will require prospective application. The Company expects that the adoption will not have a significant impact on its Consolidated Financial Statements.
 
In June 2011, the FASB issued ASU No. 2011-05, “Presentation of Comprehensive Income” which was issued to enhance comparability between entities that report under U.S. GAAP and IFRS, and to provide a more consistent method of presenting non-owner transactions that affect an entity’s equity. ASU 2011-05 eliminates the option to report other comprehensive income and its components in the statement of changes in stockholders’ equity and requires an entity to present the total of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement or in two separate but consecutive statements. This pronouncement is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and full retrospective application is required. The Company expects that the adoption will not have a significant impact on its Consolidated Financial Statements.
 
 
7

 
 
In September 2011, the FASB issued Accounting Standards Update (“ASU”) No. 2011-08, Intangibles-Goodwill and Other – Testing Goodwill for Impairment (“ASU No. 2011-08”). ASU No. 2011-08 permits an entity to make a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount before automatically applying the two-step goodwill impairment test, which has been the required test since 2002. If an entity determines that this is the case, it is necessary to perform the currently prescribed two-step goodwill impairment test to determine the amount, if any, of impaired goodwill. Otherwise, the two-step goodwill impairment test is not required.  This new guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 with early adoption permitted. We anticipate adopting this guidance in our fourth quarter of fiscal 2011 at the time we perform our annual goodwill test and do not expect that this standard will materially impact our Consolidated Financial Statements.
 
NOTE 2- EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION
 
a)  
Stock Option Expense
 
The Company's results of operations for the three months ended September 30, 2011 and 2010 include stock-based compensation expense for stock option grants totaling $44,178 and $29,766, respectively.  Such amounts have been included in the accompanying Condensed Consolidated Statements of Operations within cost of goods sold in the amount of $18,486 ($10,830 for 2010), and selling, general and administrative expenses in the amount of $25,692 ($18,936 for 2010).
 
The Company’s results of operations for the nine months ended September 30, 2011 and 2010 include stock-based compensation expense for stock option grants totaling $113,913 and $89,298, respectively.  Such amounts have been included in the accompanying Condensed Consolidated Statements of Operations within cost of goods sold in the amount of $46,315 ($32,490 for 2010), and selling, general and administrative expenses in the amount of $67,598 ($56,808 for 2010).
 
As of September 30, 2011 and 2010, there were $263,955 and $230,138 of unrecognized compensation costs, net of estimated forfeitures, related to non-vested stock options, which are expected to be recognized over a weighted average period of approximately 2.3 years and 2.3 years, respectively.
 
The following range of weighted-average assumptions were used to determine the fair value of stock option grants during the nine months ended September 30, 2011 and 2010, respectively:

   
Nine Months Ended
   
September
 
30,
   
2011
 
2010
Expected Dividend yield
 
0.00%
 
0.00%
Expected Volatility
 
100%
 
226-236%
Risk-free interest rate
 
3.4%
 
2.7-3.7%
Expected term
 
8 -10 years
 
8 -10 years
 
 
8

 
 
b)  
Stock Option Activity
 
The following table represents stock options granted, exercised and forfeited during the nine month period ended September 30, 2011:
 
Stock Options
 
Number of Options
   
Weighted Average
Exercise
Price per Option
   
Weighted Average
Remaining
Contractual Term (years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2011
    798,476     $ 1.13       5.2     $ 63,105  
Granted
    209,700       0.98                  
Exercised
    (20,000 )     0.95                  
Expired/Forfeited
    (25,900 )     3.91                  
Outstanding at September 30, 2011
    962,276     $ 1.03       6.0     $ 63,105  
                                 
Exercisable at September 30, 2011
    594,640     $ 1.02       4.2     $ 63,105  
 
The following table represents non-vested stock options granted, vested and forfeited for the nine months ended September 30, 2011.

   
Options
   
Weighted-Average Grant-Date Fair Value
 
Non-vested  - January 1, 2011
    254,525     $ 1.14  
Granted
    209,700     $ 0.89  
Vested
    (93,689 )   $ 1.19  
Forfeited
    (2,900 )   $ 0.92  
Non-vested –  September 30, 2011
    367,636     $ 0.99  
 
The total fair value of options vested during the nine months ended September 30, 2011 and 2010 was $112,000 and $60,000, respectively.
 
c)  
Restricted Stock Unit Awards
 
There were 15,000 restricted stock units granted under the 2010 Equity Compensation Program during the nine months ended September 30, 2011.  These grants vest over a three year period contingent on continued employment or service during the vesting period.
 
There were no grants during the nine months ended September 30, 2010.
 
The Company's results of operations for the three months ended September 30, 2011 and 2010 include stock-based compensation expense for restricted stock unit grants totaling $1,638 and $11,613, respectively.  Such amounts have been included in the accompanying Consolidated Statements of Operations within cost of goods sold in the amount of $0 ($1,335 for 2010), and selling, general and administrative expenses in the amount of $1,638 ($10,278 for 2010).
 
The Company’s results of operations for the nine months ended September 30, 2011 and 2010 include stock-based compensation expense for restricted stock unit grants totaling $5,401 and $32,166, respectively.  Such amounts have been included in the accompanying Consolidated Statements of Operations within cost of goods sold in the amount of $0 ($4,005 for 2010), and selling, general and administrative expenses in the amount of $5,401 ($28,161 for 2010).
 
 
9

 
 
A summary of the Company’s non-vested restricted stock units at September 30, 2011 is presented below:

   
Restricted Stock Units
   
Weighted-Average Grant-Date Fair Value
 
Non-vested - January 1, 2011
    6,998     $ 3.59  
Granted
    15,000       0.97  
Vested
    (6,998 )   $ 3.59  
Forfeited
           
Non-vested – September  30, 2011
    15,000     $ 0.97  
 
NOTE 3- STOCKHOLDERS’ EQUITY
 
For the nine months ended September 30, 2011, the Company issued 124,669 common shares to the PPGI 401k plan as a match to employee contributions for 2010 and 6,239 shares of common stock were issued on the vesting of employee stock grants, net of shares tendered to cover withholding taxes.
 
In addition, 20,000 common shares were issued for proceeds of $19,000 in connection with the exercise of stock options during the nine month period.
 
ITEM 2.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
Caution Regarding Forward Looking Statements
 
This Quarterly Report contains forward-looking statements as that term is defined in the federal securities laws.  The Company wishes to insure that any forward-looking statements are accompanied by meaningful cautionary statements in order to comply with the terms of the safe harbor provided by the Private Securities Litigation Reform Act of 1995.  The events described in the forward-looking statements contained in this Quarterly Report may not occur.  Generally, these statements relate to business plans or strategies, projected or anticipated benefits or other consequences of the Company’s plans or strategies, projected or anticipated benefits of acquisitions made by the Company, projections involving anticipated revenues, earnings, or other aspects of the Company’s operating results.  The words “may”, “will”, “expect”, “believe”, “anticipate”, “project”, “plan”, “intend”, “estimate”, and “continue”, and their opposites and similar expressions are intended to identify forward-looking statements.  The Company cautions you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks, and other influences, many of which are beyond the Company’s control, that may influence the accuracy of the statements and the projections upon which the statements are based.  Factors which may affect the Company’s results include, but are not limited to, the risks and uncertainties discussed in Items 1A, 7 and 7A of the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission on March 31, 2011.  Any one or more of these uncertainties, risks, and other influences could materially affect the Company’s results of operations and whether forward-looking statements made by the Company ultimately prove to be accurate.  Readers are further cautioned that the Company’s financial results can vary from quarter to quarter, and the financial results for any period may not necessarily be indicative of future results.  The foregoing is not intended to be an exhaustive list of all factors that could cause actual results to differ materially from those expressed in forward-looking statements made by the Company.  The Company’s actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements.  The Company undertakes no obligation to publicly update or revise any forward looking statements, whether from new information, future events, or otherwise.
 
 
10

 
 
Critical Accounting Policies and Estimates
 
Our significant accounting policies are described in Note 1 of the accompanying consolidated financial statements and further discussed in our annual financial statements included in our annual report on Form 10-K for the year ended December 31, 2010.  In preparing our condensed consolidated financial statements, we made estimates and judgments that affect the results of our operations and the value of assets and liabilities we report.  These include estimates used in evaluating goodwill and intangibles for impairment such as market multiples used in determining the fair value of reporting units, discount rates applicable in determining net present values of future cash flows, projections of future sales, earnings and cash flow and capital expenditures.  It also includes estimates about the amount and timing of future taxable income in determining the Company’s valuation allowance for deferred income tax assets.  Our actual results may differ from these estimates under different assumptions or conditions.
 
For additional information regarding our critical accounting policies and estimates, see the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report filed with the Securities and Exchange Commission on Form 10-K for the year ended December 31, 2010.
 
Results of Operations
 
Photonic Products Group, Inc.’s business falls into two general product types: Optical Components which develops, manufactures and delivers high-end precision custom optics and thin film optical coating services, and Laser System Devices and Instrumentation which includes the growth and fabrication of crystalline materials with electro-optic, non-linear and optical properties for use in both standard and custom products and the manufacture of crystal based devices and associated instrumentation.  The Optical Components product lines and services are brought to market through three brands: INRAD, Laser Optics and MRC Optics (“MRC”).  The Laser Systems Devices and Instrumentation are manufactured and sold by INRAD.  The Company operates manufacturing facilities in New Jersey and Florida.
 
Revenue
 
Sales for the three months ended September 30, 2011 were $3,329,000, an increase of 34.3% compared with $2,479,000 in the third quarter of 2010.  Sales for the nine months ended September 30, 2011 were $9,791,000, an increase of 31.4% compared with $7,451,000 for the nine months ended September 30, 2010.  This was mainly due to an increase in orders from both new customers and from existing customers in the commercial markets we serve.  Sales of optical components increased 29.7% and 20.7%, respectively, for the nine months ended September 30, 2011 and the quarter ended September 2011 compared with the prior year and sales of laser systems increased 32.3% and 58.9%, respectively, over the same periods.  Sales to the defense market were unchanged for the first nine months of 2011 compared to the same period in 2010.
 
Sales to major customers who represent more than 10% of period sales, decreased as a percentage of total sales to 36.7% in the first nine months of 2011 from 37.2% in the same period in 2010.  In addition, sales to major customers decreased to 36.8% in the third quarter of 2011 from 38.3% in the third quarter of 2010.
 
The Company’s top five customers represented 53.6% of total sales in the nine month period ended September 30, 2011, up slightly from 52.8% in the same period last year.  Although the percentage of top five customer sales did not increase significantly, one large commercial account was added to the top five customer ranks in the current period, replacing a defense customer in the comparable period last year.
 
Orders for the first nine months of 2011 increased to $10.2 million compared to $8.9 million in the first nine months of 2010, up 14.6%.
 
 
11

 
 
Order backlog increased slightly to $5.7 million at September 30, 2011compared to a backlog of $5.6 million at September 30, 2010.
 
Cost of Goods Sold
 
For the three months ended September 30, 2011, cost of goods sold decreased as a percentage of sales to 72.7% from 80.0% in 2010.   For the nine months ended September 30, 2011, cost of goods sold decreased to 73.8% as a percentage of sales from 82.7% in the same period in 2010.
 
In dollar terms, cost of goods sold was $2,421,000 compared to $1,984,000 for the three months ended September 30, 2011, up $437,000 or 22.0%.  For the nine months ended September 30, 2011 and 2010, cost of goods sold was $7,227,000, and $6,160,000, respectively, an increase of $1,067,000 or 17.3%.  The increases were attributable to higher sales in each of the comparable periods this year compared to the prior year.
 
In the third quarter and nine months ended September 30, 2011, manufacturing wages and salaries and related fringe benefits increased by 14.2% and 10.2%, respectively, principally due to an increase in direct labor to meet the increased demand and an increase in fringe benefits costs compared with the same periods in 2010.  As a percentage of sales, these manufacturing labor costs decreased both in the third quarter and the nine months ended September 30, 2011 as compared with the same period last year.
 
Material costs increased in both the third quarter and nine months ended September 30, 2011 as compared with the same period in 2010 in dollar terms and as a percentage of sales due to a shift in the product mix to sales with a higher material cost in 2011, compared to 2010.
 
Overall, gross margin in the third quarter of 2011 was $908,000 or 27.3% of sales, up compared with $495,000 or 20.0% of sales in the third quarter of 2010. For the nine months ended September 30, 2011, gross margin also increased to $2.6 million or 26.2% of sales compared with $1.3 million or 17.3% in the same period of 2010, reflecting the factors discussed and the impact of higher sales levels during the periods on the Company’s relatively fixed cost structure.
 
Selling, General and Administrative Expenses
 
Selling, general and administrative expenses (“SG&A” expenses) in the three and nine months ended September 30, 2011 were $792,000 or 23.8% of sales and $2,449,000 or 25.0% of sales, respectively, compared to $742,000 or 29.9% of sales and $2,390,000 or 32.1% of sales, respectively, for the same periods in 2010.
 
Overall, the major categories of SG&A expenses have remained relatively unchanged both on a year-to-date and quarter over quarter basis as the Company has continued to tightly manage discretionary spending.
 
Income from Operations
 
The Company had an operating income of $116,000 in the three months ended September 30, 2011 compared with an operating loss of $247,000 in the three months ended September 30, 2010, an improvement of $363,000.  For the nine months ended September 30, 2011, the Company ended with an operating income of $115,000, a significant improvement from an operating loss of $1,100,000 in the same period last year.
 
Other Income and Expense
 
For the three months ended September 30, 2011, net interest expense was $32,000, a slight decrease from $35,000 in the third quarter of last year.  For the nine months ended September 30, 2011, net interest expense was $96,000 compared to $105,000 in the same period in 2010.
 
Interest expense for the three and nine months ended September 30, 2011 was $41,000 and $123,000, respectively, which was unchanged from the comparable periods in 2010.  Interest income was $9,000 and $27,000 in third quarter of 2011 and nine months ended September 30, 2011, respectively, compared to interest income of $6,000 and $18,000 in the comparable periods last year.
 
 
12

 
 
In the first quarter of 2011, the Company sold surplus equipment and recorded a gain of $4,000 on the sale.
 
Income Taxes
 
The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns.  Deferred tax assets and liabilities are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.
 
For the three and nine months ended September 30, 2011 and 2010, the Company did not record a current provision for either state or federal income taxes due to the availability of net operating loss carryforwards to offset against federal and state income taxes.
 
As of September 30, 2011, the Company has recognized a net deferred tax asset balance in the amount of $408,000, which is the portion of the total net deferred tax balance of $2,521,000 that the Company’s management is reasonably assured will be fully utilized in future periods.  In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income consistent with the plans and estimates that management uses to manage the underlying business.  The Company’s valuation allowance of $2,113,000 as of September 30, 2011 will be maintained until management concludes that it is more likely than not that the remaining deferred tax assets will be realized. When sufficient positive evidence exists, the Company’s income tax expense will be reduced by the decrease in its valuation allowance.  An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.
 
Net Income
 
For the nine months ended September 30, 2011, the Company had a net income of $23,000, which compared favorably with a net loss of $1,205,000 for the same period in 2010.  The Company had net income of $84,000 for the three months ended September 30, 2011 compared with a net loss of $282,000 for the three months ended September 30, 2010.  The improvement in 2011 was attributable to the positive effect of the 31.4% and 34.3% increases in sales volumes for the nine months and third quarter, respectively, and improvements in gross profit margins, as discussed above.
 
Liquidity and Capital Resources
 
The Company’s primary source of cash has been from operating cash flows.  Other sources of cash include proceeds received from the exercise of stock options in return for the issuance of common stock.  The Company’s major use of cash in the past two years has been for repayment of accrued interest, servicing of outstanding debt and for capital expenditures.  Based upon the current level of operations we believe our existing cash resources, as well as cash flows from future operating activities, will be adequate to meet our anticipated requirements for working capital, principal and interest payments on outstanding debt, capital expenditures and other operating needs over next twelve months.
 
The following table summarizes net cash provided by (used by) operating, investing and financing activities for the nine months ended September 30, 2011 and 2010:
 
   
Nine Months Ended
 
     September 30,  
   
2011
   
2010
 
    (In thousands)  
Net cash (used by) provided by operating activities
 
$
(47
 
$
    297
 
Net cash (used in) investing activities
   
(542
)
   
    (124)
 
Net cash provided by financing activities
   
11
     
        1
 
Net (decrease) increase in cash and cash equivalents
 
$
(578
)
 
$
     174
 
 
 
13

 
 
Net cash used by operating activities was $47,000 for the nine months ended September 30, 2011, compared to net cash provided of $297,000 in the same period last year.  The decrease in cash from operating activities compared to the corresponding period last year resulted primarily from an increase in working capital requirements necessary to support the Company’s current level of business activity.  In particular, inventory levels increased by $490,000 to $2,881,000 at September 30, 2011 compared to an increase of $336,000 in the nine month period ended September 30, 2010.  The increase in inventory is primarily attributable to an increase in demand and timing of deliveries for orders in the current period.  In addition, the Company paid accrued interest of $900,000 and an additional $112,500 in current interest on convertible notes payable. At a minimum, the Company expects to make a payment of $37,500 in the fourth quarter of 2011 and in each quarter through the maturity date of the notes to satisfy the amounts of future interest accruing in each quarter.
 
Capital expenditures for the nine months ended September 30, 2011 were $231,000 and $124,000 in the comparable period last year.  Management continued its review of planned capital expenditures to identify and defer expenditures, where practical, to minimize the impact on the Company’s cash flows over the balance of the year.
 
In the nine months ended September 30, 2011, the Company purchased specialized tools fabricated from precious metals in the amount of $317,000.
 
Net cash provided by financing activities during the first nine months ending September 30, 2011 totaled $11,000 compared to $1,000 provided in the comparable period in 2010.  This consisted primarily of proceeds from the exercise of stock options for $19,000 in 2011 and $9,000 in 2010, offset by principal payments on long term notes of $7,000 in each period, respectively.
 
Overall, the Company had a net decrease in cash and cash equivalents of $578,000 in the nine months ended September 30, 2011 compared with an increase of $174,000 in the corresponding period last year.
 
Cash and cash equivalents at September 30, 2011 and September 30, 2010 were $3,787,000 and $4,243,000, respectively.  At December 31, 2010, the Company had $4,365,000 in cash and cash equivalents.
 
ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
The Company is a smaller reporting company and not required to provide the information required under this item.
 
ITEM 4.  CONTROLS AND PROCEDURES
 
a.
Disclosure Controls and Procedures
 
Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of September 30, 2011 (the “Evaluation Date”), have concluded that as of the Evaluation Date, our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports we file or submit under the Exchange Act (1) is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and (2) is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.
 
b.
Changes in Internal Controls over Financial Reporting
 
There were no changes in our internal control over financial reporting during the quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
14

 
 
PART II.  OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS
 
None.
 
ITEM 1A. RISK FACTORS
 
Not applicable
 
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
None.
 
ITEM 3. DEFAULTS UNDER SENIOR SECURITIES
 
None.
 
ITEM 4. [Reserved]
 
ITEM 5.     OTHER INFORMATION
 
None
 
ITEM 6.  EXHIBITS
 
11.
An exhibit showing the computation of per-share earnings is omitted because the computation can be clearly determined from the material contained in this Quarterly Report on Form 10-Q.
 
31.1  
Certificate of the Registrant’s Chief Executive Officer, Joseph J. Rutherford, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
31.2  
Certificate of the Registrant’s Chief Financial Officer, William J. Foote, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
32.1
Certificate of the Registrant’s Chief Executive Officer, Joseph J. Rutherford, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
32.2
Certificate of the Registrant’s Chief Financial Officer, William J. Foote, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
101
The following financial information from Photonic Products Group, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2011 formatted in Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to the Condensed Consolidated Financial Statements.*
 

*
Users of this interactive data file are advised pursuant to Rule 406T of Regulations S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
 
 
15

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Photonic Products Group, Inc.
 
       
 
By:
/s/Joseph J. Rutherford  
    Joseph J. Rutherford  
    President and Chief Executive Officer  
 
 
By:
/s/ William J. Foote  
    William J. Foote  
    Chief Financial Officer,  
    Secretary and Treasurer  
 
 Date: November 14, 2011

 
16